SCHEMBL6201352

SCHEMBL6201352

CCCn1nc(COCc2ccccc2)c(C(N)=O)c1NC(=O)c1cc(S(=O)(=O)N2CCN(C)CC2)ccc1OCC

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
POLB P06746 1/20 0.49
PDE5A O76074 4/20 0.43
LMNA P02545 3/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE1C Q14123 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
LRRK2 Q5S007 2/20 0.39
TSHR P16473 2/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197039 0.86 KMT2A (0.53) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL7310252 0.85 PDE5A (0.50) KMT2AMEN1PDE5APDE1APDE1B
SCHEMBL6194105 0.85 KMT2A (0.45) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL6197854 0.82 KMT2A (0.55) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL6194610 0.81 KMT2A (0.53) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL6197110 0.80 KMT2A (0.54) KMT2APOLBPDE5ALMNARAB9A
SCHEMBL6332500 0.79 KMT2A (0.52) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL6197356 0.78 SGMS2 (0.42) KMT2AMEN1LMNARXFP1
SCHEMBL7002737 0.76 KMT2A (0.53) KMT2AMEN1POLBPDE5ALMNA
SCHEMBL4565717 0.74 TERT (0.56) KMT2AMEN1POLBPDE5APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0995751-B1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER (US) 2005-06-29 EP disclosed